|
| 36467464 | Semiparametric regression modeling of the global percentile outcome. | J Stat Plan Inference | 2023 |
| 37990152 | The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17. | BMC Med Res Methodol | 2023 |
| 35929651 | Inclusion of Non-English-Speaking Participants in Studies of Parkinson's Disease: A Call to Action. | Mov Disord | 2022 |
| 34333138 | Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial. | Contemp Clin Trials | 2021 |
| 32358836 | Cost-effectiveness evaluation of the PROPPR trial transfusion protocols. | Transfusion | 2020 |
| 32838555 | Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions. | Clin Trials | 2020 |
| 27048681 | Continuous time Markov chain approaches for analyzing transtheoretical models of health behavioral change: A case study and comparison of model estimations. | Stat Methods Med Res | 2018 |
| 29454389 | Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach. | Trials | 2018 |
| 28612680 | Benefits of stroke treatment delivered using a mobile stroke unit trial. | Int J Stroke | 2018 |
| 27911341 | Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1. | J Parkinsons Dis | 2017 |
| 30363418 | Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration. | Mov Disord Clin Pract | 2017 |
| 28225739 | Damage control laparotomy utilization rates are highly variable among Level I trauma centers: Pragmatic, Randomized Optimal Platelet and Plasma Ratios findings. | J Trauma Acute Care Surg | 2017 |
| 28345011 | Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson's Disease Rating Scale. | Mov Disord Clin Pract | 2017 |
| 28207628 | Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured Patients. | Shock | 2017 |
| 28320167 | Caffeine, creatine, GRIN2A and Parkinson's disease progression. | J Neurol Sci | 2017 |
| 28965872 | Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. | Parkinsonism Relat Disord | 2017 |
| 28506500 | Autonomic and electrocardiographic findings in Parkinson's disease. | Auton Neurosci | 2017 |
| 28545336 | Design of a cluster-randomized minority recruitment trial: RECRUIT. | Clin Trials | 2017 |
| 23242384 | Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial. | Stat Methods Med Res | 2016 |
| 26491799 | The incidence of ARDS and associated mortality in severe TBI using the Berlin definition. | J Trauma Acute Care Surg | 2016 |
| 27631201 | Religiosity in black and white older Americans: Measure adaptation, psychometric validation, and racial difference. | Medicine (Baltimore) | 2016 |
| 27943473 | Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale. | Mov Disord | 2016 |
| 27476886 | Assessing protocol adherence in a clinical trial with ordered treatment regimens: Quantifying the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial experience. | Injury | 2016 |
| 27573636 | Communicating with participants during the conduct of multi-center clinical trials. | Clin Trials | 2016 |
| 27458608 | Exploring Willingness of Elder Chinese in Houston to Participate in Clinical Research. | Contemp Clin Trials Commun | 2016 |
| 26808034 | Damage-control resuscitation and emergency laparotomy: Findings from the PROPPR study. | J Trauma Acute Care Surg | 2016 |
| 26765498 | Two Decades of ICU Utilization and Hospital Outcomes in a Comprehensive Cancer Center. | Crit Care Med | 2016 |
| 23607783 | Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. | Eur J Neurol | 2015 |
| 26513489 | Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. | Cerebrovasc Dis | 2015 |
| 26366971 | Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. | Clin Neuropharmacol | 2015 |
| 26496111 | Association of transfusion red blood cell storage age and blood oxygenation, long-term neurologic outcome, and mortality in traumatic brain injury. | J Trauma Acute Care Surg | 2015 |
| 26123093 | Analysis of transtheoretical model of health behavioral changes in a nutrition intervention study--a continuous time Markov chain model with Bayesian approach. | Stat Med | 2015 |
| 25927588 | Place of Death among Hospitalized Patients with Cancer at the End of Life. | J Palliat Med | 2015 |
| 25649812 | Handling missing values in the MDS-UPDRS. | Mov Disord | 2015 |
| 25647203 | Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. | JAMA | 2015 |
| 25668262 | Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. | JAMA | 2015 |
| 25823522 | Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial. | Transfusion | 2015 |
| 25566694 | Effect of Hemoglobin Transfusion Threshold on Cerebral Hemodynamics and Oxygenation. | J Neurotrauma | 2015 |
| 24447695 | Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients. | Eur J Neurol | 2014 |
| 27891530 | Independent Spanish Validation of the Unified Dyskinesia Rating Scale. | Mov Disord Clin Pract | 2014 |
| 27747259 | IPMDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRS. | Mov Disord Clin Pract | 2014 |
| 25387194 | Erythropoietin for traumatic brain injury--reply. | JAMA | 2014 |
| 25328906 | Official Japanese Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale: validation against the original English version. | Mov Disord Clin Pract | 2014 |
| 25058216 | Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. | JAMA | 2014 |
| 24996573 | Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. | Injury | 2014 |
| 25178993 | An evaluation of differences in risk factors for individual types of surgical site infections after colon surgery. | Surgery | 2014 |
| 25150770 | Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. | Parkinsonism Relat Disord | 2014 |
| 25106063 | Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. | Lancet | 2014 |
| 24613868 | Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example. | J Parkinsons Dis | 2014 |
| 24686108 | Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: effect of availability of exception from informed consent. | Clin Trials | 2014 |